GPT and Decreased liver function: In a recent study of patients administered Abiraterone, 28% experienced adverse effects; of this group, 47.4% suffered from liver dysfunction as determined by elevated levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and/or bilirubin [67].